KVP Capital Advisors »

Bright Minds Biosciences shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 32k 72.97

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Axsome Therapeutics (AXSM)
Sutro Biopharma Com Shs (STRO)
Protagonist Therapeutics (PTGX)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Tango Therapeutics (TNGX)
Insmed Com Par $.01 (INSM)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)

View all positions for KVP Capital Advisors

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences